We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




TAVI Procedure Supported by Radial Artery Access Reduces Bleeding Complications

By HospiMedica International staff writers
Posted on 22 Oct 2024

The TAVI procedure, or Transcatheter Aortic Valve Implantation, is a minimally invasive technique in which a new aortic valve is inserted through a femoral artery to replace a narrowed old valve. More...

This method is gaining popularity, particularly among individuals aged 75-80 and those with medical risks, as it is often favored over open-heart surgery, which presents greater risks and necessitates a longer recovery period. In TAVI procedures, two femoral arteries are employed: one for introducing the aortic valve and guiding it to the correct position, and the other for injecting contrast fluid, which enhances visualization of the aorta and ensures precise valve placement. While access through the wrist has become standard practice in procedures like angioplasty to reduce the risk of severe bleeding, this approach has not yet been adopted for TAVI. Now, new research indicates that part of the TAVI procedure can be performed via the radial artery instead of the femoral artery, leading to fewer bleeding complications.

In a randomized study conducted in collaboration with multiple centers, a team of cardiologists and researchers from Radboud University Medical Center (Nijmegen, Netherlands) explored whether this technique, already established in angioplasty procedures, could also benefit the TAVI procedure involving aortic valve replacement. Patients scheduled for TAVI participated in the study and were randomly assigned to one of two groups: the standard procedure using both femoral arteries or the new method where the heart valve was introduced via the femoral artery and the contrast fluid was administered through the radial artery. A total of 238 patients took part in the study, and the findings revealed that serious bleeding requiring medical intervention occurred almost exclusively in the femoral artery group.

Additionally, the researchers made another adjustment to the procedure. During TAVI, patients typically receive a temporary pacemaker because the new valve may cause cardiac arrhythmia. While this pacemaker is usually removed immediately after the procedure, it may occasionally remain in place for several days. Traditionally, a femoral vein is used for pacemaker insertion, but in patients who had contrast fluid delivered via the wrist, the pacemaker was instead inserted through an upper-arm vein. This research, published in JAMA Network Open, highlights the advantages of using the radial artery for administering contrast fluid, as it results in fewer bleeding complications. Although this method may take slightly longer than using only femoral arteries, the team anticipates that this approach will be increasingly integrated into practice.

“This is already common in angioplasty, and we have now shown that it also provides advantages in the TAVI procedure,” said Niels van Royen, last author and professor of Cardiology. “We have been performing TAVI procedures for about fifteen years, with promising results. New aortic valves seem to function just as well after ten years as standard surgical valves. If we can reduce the risks associated with the procedure, that would be a significant step forward.”

Related Links:
Radboud University Medical Center


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Desk Aneroid Sphyg
Diagnostix 750D+
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.